Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 75 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Bobos, Mattheos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Bobos, M., Kotoula V., Kaloutsi V., Karayannopoulou G., Papadimitriou C. S., & Kostopoulos I. (2009).  Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.. Histol Histopathol. 24(8), 1035-48.
Kotoula, V., Bobos M., Alexopoulou Z., Papadimitriou C., Papadopoulou K., Charalambous E., et al. (2014).  Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.. PLoS One. 9(8), e103707.
Koletsa, T., Stavridi F., Bobos M., Kostopoulos I., Kotoula V., Eleftheraki A. G., et al. (2014).  alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.. BMC Clin Pathol. 14, 28.
Lakis, S., Kotoula V., Eleftheraki A. G., Batistatou A., Bobos M., Koletsa T., et al. (2014).  The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.. Breast. 23(3), 234-43.
B
Apalla, Z., Bobos M., Lallas A., Lazaridou E., & Katodritou E. (2020).  Bortezomib induced purpuric rash.. Dermatol Ther. 33(4), e13651.
C
Apalla, Z., Nikolaidou C., Lallas A., Sotiriou E., Lazaridou E., Venizelos I., et al. (2018).  Clinicopathologically problematic melanocytic tumors: a case-based review.. Dermatol Pract Concept. 8(4), 306-313.
Athanasiou, E., Michalopoulou-Manoloutsiou E., Bobos M., Hatzibougias D. I., Zarogoulidis P., Katsikogiannis N., et al. (2016).  Coincidence of thymoma and breast cancer and in a 56-year-old female patient.. Ann Transl Med. 4(22), 446.
Apalla, Z., Giakouvis V., Gavros Z., Lazaridou E., Sotiriou E., Bobos M., et al. (2019).  Complete response of locally advanced basosquamous carcinoma to vismodegib in two patients.. Eur J Dermatol. 29(1), 102-104.
Batistatou, A., Kotoula V., Bobos M., Kouvatseas G., Zagouri F., Tsolaki E., et al. (2018).  Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.. Clin Breast Cancer. 18(1), 53-62.e3.
Tsakiri, K., Kotoula V., Lakis S., üller J., Fostira F., Bobos M., et al. (2017).  Crizotinib Failure in a TPM4-ALK –Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation. JCO Precision Oncology. 1 - 7.
D
Cuevas, R. González, Villani A., Apalla Z., Kyrgidis A., Bagolini L. Peruilh, Papageorgiou C., et al. (2020).  Dermatoscopic predictors of melanoma arising in small- and medium-sized congenital nevi.. J Am Acad Dermatol.
Peruilh-Bagolini, L., Apalla Z., Gonzalez-Cuevas R., Lallas K., Papageorgiou C., Bobos M., et al. (2020).  Dermoscopic predictors to discriminate between in situ and early invasive lentigo maligna melanoma: A retrospective observational study.. J Am Acad Dermatol. 83(1), 269-271.
Apalla, Z., Koukouthaki A., Sidiropoulos T., Psarakis E., Nikolaidou C., Bobos M., et al. (2019).  Dermoscopy of papuloerythroderma of Ofuji.. Photodermatol Photoimmunol Photomed. 35(2), 127-128.
Papageorgiou, C., Apalla Z., Bobos M., Gkentsidi T., Kyrgidis A., Lallas K., et al. (2019).  Dermoscopy of Spitz/Reed naevi and management.. G Ital Dermatol Venereol. 154(4), 457-465.
Angelidis, A. S., Tirodimos I., Bobos M., Kalamaki M. S., Papageorgiou D. K., & Arvanitidou M. (2011).  Detection of Helicobacter pylori in raw bovine milk by fluorescence in situ hybridization (FISH).. Int J Food Microbiol. 151(2), 252-6.
Fountzilas, G., Dafni U., Bobos M., Batistatou A., Kotoula V., Trihia H., et al. (2012).  Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel.. PLoS One. 7(6), e37946.
Fountzilas, E., Kotoula V., Zagouri F., Giannoulatou E., Kouvatseas G., Pentheroudakis G., et al. (2016).  Disease evolution and heterogeneity in bilateral breast cancer.. Am J Cancer Res. 6(11), 2611-2630.
E
Kotoula, V., Karavasilis V., Zagouri F., Kouvatseas G., Giannoulatou E., Gogas H., et al. (2016).  Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.. Breast Cancer Res Treat. 158(2), 307-21.
Razis, E., Pentheroudakis G., Rigakos G., Bobos M., Kouvatseas G., Tzaida O., et al. (2014).  EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.. J Cancer Res Clin Oncol. 140(5), 737-48.
Batistatou, A., Televantou D., Bobos M., Eleftheraki A. G., Kouvaras E., Chrisafi S., et al. (2013).  Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays.. Anticancer Res. 33(5), 2139-45.
Christodoulou, C., Oikonomopoulos G., Koliou G. Angeliki, Kostopoulos I., Kotoula V., Bobos M., et al. (2018).  Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.. Cancer Genomics Proteomics. 15(6), 461-471.
Fountzilas, G., Dafni U., Bobos M., Kotoula V., Batistatou A., Xanthakis I., et al. (2013).  Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.. BMC Cancer. 13, 163.
Koutras, A., Kalogeras K. T., Wirtz R. M., Alexopoulou Z., Bobos M., Zagouri F., et al. (2015).  Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.. J Transl Med. 13, 171.
Koutras, A., Lazaridis G., Koliou G-A., Kouvatseas G., Christodoulou C., Pectasides D., et al. (2018).  Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.. PLoS One. 13(12), e0207707.
G
Psoma, E., Koliou G-A., Dimitrakopoulos F-I., Papadopoulou K., Rontogianni D., Bobos M., et al. (2020).  Genetic Variations of Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma.. Anticancer Res. 40(2), 677-688.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές